Smartlens, Inc. Secures $5.2 Million Bridge Round to Advance FDA Clearance Process and Prepare for Commercial Launch of miLens

Round Led by Ambit Health Ventures Positions Smartlens for Market Entry and Future Growth SUNNYVALE, Calif., Oct. 14, 2025 /PRNewswire/ -- Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of...